ClinicalTrials.Veeva

Menu
P

Providere Research Inc. | West Covina, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Naltrexone Hydrochloride
Bupropion Hydrochloride
EVO100
Aroxybutynin
Bempedoic acid
Atomoxetine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only
OSA
Drug: Aroxybutynin and Atomoxetine

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination

Trial sponsors

Apnimed logo
C
Esperion Therapeutics logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems